Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
VERA
VERA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest VERA ETF News Today | Earnings, Events & Price Alerts
VERA News
Vera Therapeutics Raises $261M in Public Offering at $42.50 per Share
5d ago
seekingalpha
Vera Therapeutics Appoints New Chief Commercial Officer
Jan 28 2026
Newsfilter
Vera Therapeutics Grants 344,750 Stock Options and RSUs to New Employees
Jan 09 2026
Globenewswire
Vera Therapeutics Files BLA for Atacicept in IgAN, Target Action Date July 7, 2026
Jan 09 2026
Newsfilter
Vera Therapeutics Submits IgAN Drug Application, Receives FDA Priority Review
Jan 08 2026
Fool
Vera Therapeutics Submits Kidney Drug Application, Receives FDA Priority Review
Jan 08 2026
NASDAQ.COM
Vera Therapeutics Receives FDA Priority Review for Atacicept BLA
Jan 07 2026
Benzinga
Wells Fargo Sees Rebound Potential in Heavily Shorted Stocks, Herc Target Price Implies 27% Upside
Jan 06 2026
CNBC
Insider Buying Update for Tuesday, December 16: ASST and VERA
Dec 16 2025
NASDAQ.COM
Vera Therapeutics Prices Public Offering at $42.50, Raising Approximately $261 Million
Dec 10 2025
Newsfilter
Vera Therapeutics Grants 63,000 Stock Options and RSUs to New Employees
Dec 05 2025
Globenewswire
Vera Therapeutics Grants 42,000 Stock Options to New Employees
Dec 05 2025
Newsfilter
Three Stocks Projected to Have Triple-Digit Growth Potential, According to Top Analysts – 11/26/2025
Nov 26 2025
TipRanks
Vera Therapeutics Appoints Biopharma Executive Jim Meyers to Board Amid Atacicept Launch Preparations
Nov 26 2025
Newsfilter
Nutanix Reports Disappointing Q1 Results, Alongside HP, Ambarella, Pagerduty, and Other Major Stocks Declining in Wednesday's Pre-Market Trading
Nov 26 2025
Benzinga
Vera Therapeutics to Present at Upcoming Investor Conferences on Immunological Treatments
Nov 24 2025
Newsfilter
Show More News
